What's breaking now, across thousands of outlets.
In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Verastem Oncology had a big Wednesday morning: it announced new data amid a tense competition for the next-wave KRAS agents, as well as a $250 million raise and the departure of its CEO.
Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.
Orihuela Town Hall has called for more accessible mental health support and greater understanding of emotional difficulties at an event marking World Mental Health Day.
Shorter cell expansion steps could significantly accelerate CAR T-cell therapy production processes, according to researchers, who cite microfluidic culture systems, real-time PAT tools, and…
Splitting lipid nanoparticle manufacturing into multiple mixing steps can help better control the size, shape, and stability of particles, with the aim of improving product quality during…
